Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets
These ODTs contain the Active Pharmaceutical Ingredient (API) Tadalafil and maintain the same exceptional flavor as MangoRx's other ED products.
- These ODTs contain the Active Pharmaceutical Ingredient (API) Tadalafil and maintain the same exceptional flavor as MangoRx's other ED products.
- The initial batch is currently undergoing testing by a third-party U.S. laboratory to ensure consistency and quality.
- “This achievement marks a significant milestone in our expansion into the Mexican and Latin American markets,” stated Jacob Cohen, MangoRx’s Co-Founder and CEO.
- This will further pave the way for obtaining the necessary certification to begin marketing and selling Mango ED products across Mexico.